Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

Thomson, C.S., Twelves, C.J., Mallon, E.A. and Leake, R.E. (2002) Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status. Breast, 11, pp. 419-429. (doi: 10.1054/brst.2002.0451)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mallon, Dr Elizabeth
Authors: Thomson, C.S., Twelves, C.J., Mallon, E.A., and Leake, R.E.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Breast

University Staff: Request a correction | Enlighten Editors: Update this record